US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Oncology Therapeutics, Inc

10.70

+0.55005.42%

Post-market: 10.60-0.1000-0.93%19:05 EST

Volume:520.90K

Turnover:5.67M

Market Cap:855.88M

PE:-1.04

High:11.55

Open:10.50

Low:10.22

Close:10.15

52wk High:14.87

52wk Low:8.50

Shares:79.99M

Float Shares:44.60M

Volume Ratio:2.30

T/O Rate:1.17%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-10.3075

EPS(LYR):-511.8002

ROE:--

ROA:--

PB:1.92

PE(LYR):-0.02

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

BridgeBio Oncology Therapeutics Grants Inducement Stock Options Under 2025 Plan

BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

BridgeBio Oncology price target lowered to $18 from $20 at Morgan Stanley

BridgeBio Oncology Therapeutics (BBOT) Receives a Buy from Piper Sandler

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BBOT"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBOT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBOT\",,,,,undefined,":{"symbol":"BBOT","market":"US","secType":"STK","nameCN":"BridgeBio Oncology Therapeutics, Inc","latestPrice":10.7,"timestamp":1770411600000,"preClose":10.15,"halted":0,"volume":520902,"hourTrading":{"tag":"盘后","latestPrice":10.6,"preClose":10.7,"latestTime":"19:05 EST","volume":426,"amount":4516.1,"timestamp":1770422707034,"change":-0.1,"changeRate":-0.009346,"amplitude":0.009346},"delay":0,"changeRate":0.05418719211822649,"floatShares":44603977,"shares":79988687,"eps":-10.307472,"marketStatus":"Market Closed","change":0.55,"latestTime":"02-06 16:00:00 EST","open":10.5,"high":11.55,"low":10.215,"amount":5670519.6381749995,"amplitude":0.131527,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-10.307472,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"listingDate":1707454800000,"exchange":"NASDAQ","adjPreClose":10.15,"postHourTrading":{"tag":"盘后","latestPrice":10.6,"preClose":10.7,"latestTime":"19:05 EST","volume":426,"amount":4516.1,"timestamp":1770422707034,"change":-0.1,"changeRate":-0.009346,"amplitude":0.009346},"volumeRatio":2.2971633275689363},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBOT\",,,,,undefined,":{"symbol":"BBOT","floatShares":44603977,"roa":"--","roe":"--","lyrEps":-511.800172,"volumeRatio":2.2971633275689363,"shares":79988687,"dividePrice":0,"high":11.55,"amplitude":0.131527,"preClose":10.15,"low":10.215,"week52Low":8.5,"pbRate":"1.92","week52High":14.87,"institutionHeld":0,"latestPrice":10.7,"eps":-10.307472,"divideRate":0,"volume":520902,"delay":0,"ttmEps":-10.307472,"open":10.5,"prevYearClose":12.52,"prevWeekClose":11.72,"prevMonthClose":11.72,"prevQuarterClose":12.52,"fiveDayClose":11.72,"twentyDayClose":13.3,"sixtyDayClose":12.69},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBOT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"BBOT","fiscalQuarterEnding":"2025/09","expectedEps":-0.41,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-1.03},{"market":"US","date":"2025-08-01","symbol":"BBOT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754020800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-05-15","symbol":"BBOT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-14","symbol":"BBOT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBOT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBOT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.625,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1768021200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BBOT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BBOT","date":"2026-02-06","current":-1.038082,"percent":1,"low":-11.944957,"twenty":-10.867923,"median":-9.470009,"eighty":-8.485061,"high":-7.063925,"avg":-9.553405,"sd":1.173639,"marketCap":811885173},"quantilePoints":[{"date":"2025-08-22","current":-9.544109,"twenty":-10.820609,"median":-9.81087,"eighty":-9.532253,"marketCap":835109579},{"date":"2025-08-29","current":-9.336629,"twenty":-9.787158,"median":-9.514469,"eighty":-9.277349,"marketCap":816955023},{"date":"2025-09-05","current":-9.959071,"twenty":-9.864223,"median":-9.514469,"eighty":-9.247708,"marketCap":871418691},{"date":"2025-09-12","current":-10.047991,"twenty":-10.065775,"median":-9.65773,"eighty":-9.388005,"marketCap":879199215},{"date":"2025-09-19","current":-10.690193,"twenty":-10.20212,"median":-9.78123,"eighty":-9.467045,"marketCap":935391888},{"date":"2025-09-26","current":-11.678196,"twenty":-11.017222,"median":-9.944251,"eighty":-9.487793,"marketCap":1021842155},{"date":"2025-10-03","current":-11.259509,"twenty":-11.190123,"median":-10.077631,"eighty":-9.526325,"marketCap":985207072},{"date":"2025-10-10","current":-11.196152,"twenty":-11.224546,"median":-10.323455,"eighty":-9.563869,"marketCap":979663302},{"date":"2025-10-17","current":-10.3182,"twenty":-11.192532,"median":-10.372506,"eighty":-9.601414,"marketCap":902842494},{"date":"2025-10-24","current":-9.838494,"twenty":-11.156298,"median":-10.223893,"eighty":-9.601414,"marketCap":860868237},{"date":"2025-10-31","current":-10.861263,"twenty":-11.08659,"median":-10.23674,"eighty":-9.656742,"marketCap":950360520},{"date":"2025-11-07","current":-11.087539,"twenty":-11.118284,"median":-10.345353,"eighty":-9.745662,"marketCap":970159697},{"date":"2025-11-14","current":-11.205203,"twenty":-11.201583,"median":-10.472068,"eighty":-9.804136,"marketCap":980455269},{"date":"2025-11-21","current":-8.47671,"twenty":-11.192532,"median":-10.345353,"eighty":-9.572151,"marketCap":974262207},{"date":"2025-11-28","current":-8.567184,"twenty":-11.17443,"median":-10.251046,"eighty":-9.478901,"marketCap":984660736},{"date":"2025-12-05","current":-8.0313,"twenty":-11.121014,"median":-10.182434,"eighty":-9.298176,"marketCap":923069447},{"date":"2025-12-12","current":-8.936039,"twenty":-11.105583,"median":-10.084778,"eighty":-9.061365,"marketCap":1027054741},{"date":"2025-12-19","current":-8.389716,"twenty":-11.080298,"median":-9.97426,"eighty":-8.826299,"marketCap":964263621},{"date":"2025-12-26","current":-8.490629,"twenty":-11.051335,"median":-9.938056,"eighty":-8.720294,"marketCap":975861981},{"date":"2026-01-02","current":-8.713334,"twenty":-11.00789,"median":-9.919954,"eighty":-8.650698,"marketCap":1001458361},{"date":"2026-01-09","current":-9.256178,"twenty":-10.960825,"median":-9.809862,"eighty":-8.597806,"marketCap":1063849537},{"date":"2026-01-16","current":-8.003462,"twenty":-10.901088,"median":-9.61327,"eighty":-8.567184,"marketCap":919869900},{"date":"2026-01-23","current":-7.829474,"twenty":-10.885701,"median":-9.557912,"eighty":-8.530995,"marketCap":899872728},{"date":"2026-01-30","current":-8.699415,"twenty":-10.880305,"median":-9.521034,"eighty":-8.553265,"marketCap":999858587},{"date":"2026-02-06","current":-7.063925,"twenty":-10.867923,"median":-9.470009,"eighty":-8.485061,"marketCap":811885173}],"updateTime":1770550567027},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBOT\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2603663002","title":"BridgeBio Oncology Therapeutics Grants Inducement Stock Options Under 2025 Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2603663002","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603663002?lang=en_us&edition=fundamental","pubTime":"2026-01-14 05:05","pubTimestamp":1768338313,"startTime":"0","endTime":"0","summary":"BridgeBio Oncology Therapeutics Inc. has announced the granting of non-qualified stock options to a newly hired employee. The grant covers 129,090 shares of BBOT common stock at an exercise price of $13.19 per share, matching the company’s closing price on the grant date. The options will vest with one quarter becoming available on the first anniversary of the employee’s start date, and the remainder vesting in 36 equal monthly installments, contingent on continued employment.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bridgebio Oncology Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on January 13, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDL2fndr8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4585","LU0314104364.USD","BK4112","BBIO","NDAQ","IE00BKPKM429.USD","LU2210149790.SGD","LU2210150020.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","SG9999014013.SGD","BBOT","SG9999014021.USD","BK4588","IE00B3QW5Z07.USD","SG9999014039.USD","BK4139","LU2095319765.USD","SG9999014005.SGD"],"gpt_icon":0},{"id":"2603865840","title":"BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2603865840","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603865840?lang=en_us&edition=fundamental","pubTime":"2026-01-14 05:05","pubTimestamp":1768338300,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Jan.  13, 2026  (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc., or BBOT (NASDAQ: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malign","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/13/3218252/0/en/BridgeBio-Oncology-Therapeutics-Reports-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","BBOT","LENZ","BK4007"],"gpt_icon":0},{"id":"2601583364","title":"BridgeBio Oncology price target lowered to $18 from $20 at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2601583364","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601583364?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:51","pubTimestamp":1767876672,"startTime":"0","endTime":"0","summary":"Morgan Stanley lowered the firm’s price target on BridgeBio Oncology (BBOT) to $18 from $20 and keeps an Overweight rating on the shares. The firm ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bridgebio-oncology-price-target-lowered-to-18-from-20-at-morgan-stanley-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bridgebio-oncology-price-target-lowered-to-18-from-20-at-morgan-stanley-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2089284900.SGD","LU1732799900.SGD","LU2133065610.SGD","LU1791710400.SGD","LU2089283258.USD","IE00BKVL7J92.USD","LU1363072403.SGD","LU0795875169.SGD","LU1548497426.USD","BK4588","LU0971096721.USD","LU0234570918.USD","LU1720051017.SGD","LU0314104364.USD","LU1720051108.HKD","BK4504","LU0158827781.USD","LU2347655156.SGD","LU2028103732.USD","LU1074936037.SGD","BK4139","LU0106261372.USD","LU0225283273.USD","LU0528227936.USD","BBOT","LU0098860793.USD","LU1989772840.SGD","LU2271345857.HKD","LU0795875086.SGD","LU1244550494.USD","BK4585","LU0006306889.USD","LU0912757837.SGD","BK4516","BK4534","LU0882574139.USD","LU2023251221.USD","LU0267386448.USD","LU1244550577.SGD","LU0106831901.USD","LU1732800096.USD","LU2111349929.HKD","BK4127","IE00BZ1G4Q59.USD","LU1162221912.USD","BK4581","LU1668664300.SGD","LU1244550221.USD","LU0158827948.USD","LU0557290698.USD"],"gpt_icon":0},{"id":"2601369952","title":"BridgeBio Oncology Therapeutics (BBOT) Receives a Buy from Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2601369952","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601369952?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:17","pubTimestamp":1767874661,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Biren Amin maintained a Buy rating on BridgeBio Oncology Therapeutics today and set a price target of $21.00. According to Ti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bridgebio-oncology-therapeutics-bbot-receives-a-buy-from-piper-sandler-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bridgebio-oncology-therapeutics-bbot-receives-a-buy-from-piper-sandler-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BBOT"],"gpt_icon":0}],"pageSize":4,"totalPage":10,"pageCount":1,"totalSize":40,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BBOT\",params:#limit:6,delay:false,,,undefined,":[]}}